Quest Diagnostics

The path to a diagnosis can be a long and arduous journey for the patients affected by rare diseases. This Rare Disease Day, we honor the courage and resilience of the millions of people navigating this path. “When taken together, ‘rare’ diseases affect one in ten people, making them a significant public health opportunity,” said Dr Sarah South, Executive Director of Clinical Genomics at Quest Diagnostics. “Advances in comprehensive genomic sequencing now allow a single test to provide new insights across thousands of rare diseases—accelerating our pursuit of truly personalized diagnostic insights.” #RareDiseaseDay

Quest was honored to join experts from the Florida Institute for Pediatric Rare Diseases @FSU (IPRD) and Florida State University College of Medicine during a symposium focused on the understanding, diagnosis, and treatment of rare diseases. Distinguished panelists included: David Ledbetter, Associate Director of the Florida IPRD, moderator Richard McCullough, President, Florida State University Adam Anderson, CFP®, CRPC, Florida House of Representative and Rare Disease Advocate Dr Eric Green, M.D., Ph.D., Chief Medical Officer, Illumina Dr Sarah South, Executive Director of Clinical Genomics, Quest Diagnostics Florida Rep. Adam Anderson, who sponsored the Sunshine Genetics Act and championed the budget appropriation for the Florida IPRD, made remarks about the importance of equitable access and social support for the patients and families affected by rare diseases. #FSU #RareDiseaseDay #QuestDiagnostics #SunshineGeneticsAct

Quest is committed to helping you enhance the patient experience. We go beyond test results, working hard every day to provide ✅ Greater convenience ✅ Real-time results sharing ✅ Seamless patient care journey And now, millions of Anthem Blue Cross and Blue Shield members in GA, CO, NV, and VA have access to an elevated healthcare experience and Quest’s quality lab testing. Learn more: QuestInNetwork.com/Anthem Quest was selected as a preferred provider for all Anthem Blue Cross and Blue Shield products in CO, GA, and NV, and for all Anthem Blue Cross and Blue Shield and its affiliate HealthKeepers, Inc. products in VA. Quest Diagnostics Incorporated is an independent company providing lab services to Anthem health plan members.

Anyone can be exposed to forever chemicals by consuming PFAS-contaminated water or food, using products made with PFAS, or breathing PFAS-contaminated air. The buildup of certain PFAS in blood and organs has been associated with the risk of developing various medically related issues. Our new article discusses the importance of laboratory testing to assess the presence of PFAS. Read more at http://spr.ly/6045hqVFD

At this year’s SCbio Life + Science Conference, Gaurav Malik, VP of Quest Diagnostics Southeast Region welcomed more than 400 life sciences professionals to Charleston, SC. His remarks reflected the power of collaboration across our industry and the critical role we all play in advancing care and strengthening the health of our communities. Thank you to SCbio for the collaboration and for convening leaders committed to shaping the future of life sciences in South Carolina.

Pharmacogenetics (PGx) testing can transform how clinicians select and dose medications by accounting for individual genetic variability in drug metabolism, transport, and response. Learn more about how large an impact PGx testing could have in our latest Healthier World episode: http://spr.ly/6042hmkWy

We're proud to share that our CEO, Jim Davis has been named to the 2026 Power 100 list by NJBIZ. This recognition reflects his steady leadership and continued focus on advancing diagnostic innovation to improve patient care. To view the full list visit: http://spr.ly/6044hjGjO #NJBIZPowerList #NewJerseyLeaders #Power100

Quest's strategy to advance blood-based testing is helping create a healthier world, one life at a time. This week, our CEO Jim Davis shared with Bloomberg Television how we are driving innovation across critical disease states, like cancer and Alzheimer's, to enable earlier detection and illuminate informed care decisions.

Blood biomarker science for Alzheimer's disease is advancing rapidly, reshaping how cognitive symptoms are evaluated and understood. With new evidence emerging at an unprecedented pace, staying current matters more than ever. Our experts are committed to advancing biomarker science and helping keep physicians up-to-date as the evidence evolves. Learn how our biomarker portfolio reflects and helps advance ongoing scientific progress. http://spr.ly/6044h3NcO

Type 1 diabetes (T1D) is an autoimmune disease that remains underrecognized, especially in adults, but can lead to serious complications such as diabetic ketoacidosis when diagnosis is delayed or missed. Listen to our Healthier World episode to learn more: http://spr.ly/6041h30f7